Adjusted mean differences and 95% confidence intervals for total YMRS and HAM-D-21 change scores at endpoint with paliperidone ER versus placebo in patients with manic or depressive symptoms at baseline (intent-to-treat analysis set).
Notes: Analysis is based on an ANCOVA model with fixed effects for treatment, study, country nested within study, and the baseline value as a covariate. aP ≤ 0.001, paliperidone ER versus placebo; bP < 0.05, paliperidone ER versus placebo.
Abbreviations: CI, confidence interval; ER, extended-release; HAM-D-21, 21-item Hamilton Rating Scale for Depression; LS, least-squares; MS/ADs, mood stabilizers/ antidepressants; PANSS, Positive and Negative Syndrome Scale; YMRS, Young Mania Rating Scale.